WAM
LSB

Wolverine Asset Management’s LakeShore Biopharma LSB Stock Holding History

Wolverine Asset Management’s Portfolio LSB Stock Details LSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50
Closed -$359 – 1811
2024
Q1 		$359 Hold
50
– – ﹤0.01% 1582
2023
Q4 		$254 Hold
50
– – ﹤0.01% 1691
2023
Q3 		$399 Hold
50
– – ﹤0.01% 1763
2023
Q2 		$688 Hold
50
– – ﹤0.01% 1668
2023
Q1 		$798 Buy
+50
New +$2.53K ﹤0.01% 1727

Other funds holding LSB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OCM
Ovata Capital Management Hong Kong $1.33B AUM 5.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Asset Management's LSB Position: Q2 2024 in Review

Wolverine Asset Management sold out of LakeShore Biopharma (LSB) in Q2 2024, closing a stake of 50 shares — an estimated $359 sold.

Wolverine Asset Management first reported a position in LSB in Q1 2023 and held it in 5 quarters. The position peaked at $798 in Q1 2023. 11 funds tracked by Wall St. Rank hold LSB as of Q2 2024.

  • Wolverine Asset Management reported no remaining LakeShore Biopharma position as of Q2 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 50 LakeShore Biopharma shares in Q2 2024, an estimated $359.
  • Wolverine Asset Management first reported a position in LakeShore Biopharma in Q1 2023 and held it in 5 quarters.
  • Wolverine Asset Management's LakeShore Biopharma position peaked at $798 in Q1 2023.
  • 11 funds tracked by Wall St. Rank held LakeShore Biopharma as of Q2 2024.

Based on Wolverine Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.